InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the complete record of transactions filed by Vivo Capital IX, LLC. Insider active across 2 companies, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 8 reports have been logged. Total volume traded: €7.1m. The latest transaction was filed on 5 May 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€62,4605,374 shares@ €11.62270.0023% mcap0.9% of flow
Common Stock
SEC:0001213900-22-024317:0·
€604,18541,800 shares@ €14.45420.022% mcap8.5% of flow
Common Stock
SEC:0001213900-22-024052:0·
2,365,545 shares
Common Stock
SEC:0001140361-21-037658·
2,365,545 shares
Common Stock
SEC:0001140361-21-037658:0·
€948,45237,980 shares@ €24.97240.035% mcap29.3% of flow
Common Stock
SEC:0001213900-21-034310·
€2m91,620 shares@ €24.93170.085% mcap70.7% of flow
Common Stock
SEC:0001213900-21-034298·
€2m91,620 shares@ €24.93170.085% mcap32.0% of flow
Common Stock
SEC:0001213900-21-034298:0·
€948,45237,980 shares@ €24.97240.035% mcap13.3% of flow
Common Stock
SEC:0001213900-21-034310:0·
8 of 8 declarations
About Vivo Capital IX, LLC
Vivo Capital IX, LLC is a director and insider at Tarsus Pharmaceuticals, Inc. and IO Biotech, Inc.
